Wei Zheng holds 6.2% of Connect Biopharma (CNTB) after March offering

Rhea-AI Filing Summary

Connect Biopharma Holdings Ltd reports that Wei Zheng beneficially owns 3,876,036 ordinary shares, representing 6.2% of the class. The percentage is calculated using 56,521,282 Ordinary Shares outstanding as of March 26 and the 6,130,000 Ordinary Shares issued in the Offering disclosed on March 30, 2026.

The filing attributes sole voting and dispositive power over the 3,876,036 shares to Wei Zheng. The report updates prior Schedule 13G holdings and provides the ownership stake as of the cited disclosure dates.

Insights

Corporate Governance Analyst

Wei Zheng is a disclosed >5% owner with sole voting and dispositive power.

The filing lists 3,876,036 shares held by Wei Zheng, equal to 6.2% of the outstanding ordinary shares based on the issuer's disclosure as of March 26. This places the holder above the 5% reporting threshold that triggers Schedule 13G/A reporting obligations.

Ownership above 5% requires continued periodic reporting; subsequent filings may show changes if shares are acquired or sold. Cash-flow treatment or transaction timing is not stated in the excerpt.

Investor Relations Specialist

The ownership calculation references both outstanding shares and a recent offering disclosed on March 30, 2026.

The percentage is explicitly tied to 56,521,282 Ordinary Shares outstanding as of March 26 and the 6,130,000 shares issued in the Offering. That citation clarifies the denominator used to compute the 6.2% stake.

Shareholders and market participants seeking updates should review future amendments or transactions; this excerpt does not disclose subsequent trades or changes after the cited dates.

Key Figures

Reported shares beneficially owned: 3,876,036 shares Percent of class: 6.2% Shares outstanding used in calculation: 56,521,282 Ordinary Shares +1 more

4 metrics

Reported shares beneficially owned 3,876,036 shares Amount beneficially owned by Wei Zheng (Item 4)

Percent of class 6.2% Percent of Ordinary Shares attributed to Wei Zheng

Shares outstanding used in calculation 56,521,282 Ordinary Shares Outstanding as of <date>March 26</date> per issuer's 10-K

Shares issued in Offering 6,130,000 Ordinary Shares Issued by the issuer in connection with the Offering disclosed on <date>March 30, 2026</date>

Key Terms

Schedule 13G/A, Beneficial ownership, Sole dispositive power

3 terms

Schedule 13G/A regulatory

"Amendment No. 5 ) Connect Biopharma Holdings Ltd"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

Beneficial ownership financial

"Amount beneficially owned: 3,876,036.00"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Sole dispositive power regulatory

"Sole power to dispose or to direct the disposition of: 3,876,036.00"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/15/2026 - 01:47 PM Learn about SEC filing dates

FAQ

What stake does Wei Zheng report in CNTB?

Wei Zheng reports beneficial ownership of 3,876,036 ordinary shares, equal to 6.2% of the class as stated in the filing, based on the issuer's disclosed share counts.

How was the 6.2% ownership percentage calculated for CNTB?

The percentage uses 56,521,282 Ordinary Shares outstanding as of March 26 and the 6,130,000 Ordinary Shares issued in the Offering disclosed on March 30, 2026, per the filing.

Does Wei Zheng have voting and dispositive power over these CNTB shares?

Yes. The filing shows Wei Zheng has sole voting power and sole dispositive power over 3,876,036 shares, with no shared voting or dispositive power reported.

Are the share counts tied to a specific date in the CNTB filing?

Yes. The outstanding share figure cited is as of March 26, and the Offering that issued additional shares is disclosed on March 30, 2026, both used in the percentage calculation.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 5)

Connect Biopharma Holdings Ltd

(Name of Issuer)

Ordinary shares, par value $0.000174

(Title of Class of Securities)

207523101

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 207523101

1

Names of Reporting Persons

Wei Zheng

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 3,876,036.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 3,876,036.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,876,036.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.2 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: The percentage of beneficial ownership reported here is based on (i) 56,521,282 Ordinary Shares outstanding as of March 26 as disclosed in the Issuer's 10-K reported on March 31, 2026, and (ii) the 6,130,000 Ordinary Shares issued by the Issuer in connection with the Offering, as disclosed in the 8-K filed on March 30, 2026.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Connect Biopharma Holdings Ltd
(b)	Address of issuer's principal executive offices: 3580 CARMEL MOUNTAIN ROAD, SUITE 200, SAN DIEGO, CALIFORNIA, 92130.
Item 2.
(a)	Name of person filing: Wei Zheng
(b)	Address or principal business office or, if none, residence: PO Box 415 Del Mar, CA 92014
(c)	Citizenship: US
(d)	Title of class of securities: Ordinary shares, par value $0.000174
(e)	CUSIP No.: 207523101
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 3,876,036.00
(b)	Percent of class: 6.2%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 3,876,036.00
	(ii) Shared power to vote or to direct the vote: 0.00
	(iii) Sole power to dispose or to direct the disposition of: 3,876,036.00
	(iv) Shared power to dispose or to direct the disposition of: 0.00
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.	Certifications:
	Not Applicable

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Wei Zheng

Signature:	Zheng Wei
Name/Title:	Individual
Date:	05/15/2026